INTRODUCTION
Allergic asthma is a chronic inflammatory disease of the airways that is mainly driven by maladaptive T helper type 2 (Th2) immune responses. Several reports have demonstrated that pulmonary dendritic cells (DC) have a key role in the uptake and processing of aeroallergens and the differentiation of naive CD4 þ T cells into allergen-specific Th2 effector cells. 1 Under steady state conditions, CD11c hi conventional DCs (cDC) and CD11c lo plasmacytoid DCs (pDC) reside in the lung. cDCs can be further subdivided into CD11b þ CD103 À and CD11b À CD103 þ cells, both of which contribute to allergen uptake, processing, and activation of CD4 þ T cells. The exact role of the two cDC populations in Th-cell differentiation remains elusive. Two reports suggest that CD11b þ CD103
À DCs preferentially promote differentiation of Th2 effector cells, 2, 3 whereas CD11b À CD103 þ DCs induce Th1 and Th17 effector cells. 3 By contrast, Nakano et al. 4 found that CD11b þ CD103 À cells preferentially drive Th1 and CD11b À CD103
þ DCs Th2 differentiation. The function of pDCs is to control and protect the lung environment from unwanted cDC-instructed maladaptive immunity. 5, 6 The exact mechanisms underlying the activation of the distinct DC subpopulations under steady state and inflammatory conditions are still incompletely understood. Evidences from epidemiological studies and experimental asthma models suggest that environmental factors, including the exposure to inhaled allergens or pollutants, and microbial infections are critical. The emerging paradigm is that environmental and microbial molecules activate conserved humoral and cellular sensing systems of the innate immune system and that the integration of such signals defines the activation program of pulmonary DCs, i.e., to keep pulmonary tolerance or to initiate and drive adaptive immune responses. 1 Microbial components within aeroallergens such as lipopolysaccharide can activate the complement system and generate the anaphylatoxins C3a and C5a. Moreover, allergen-derived proteases can directly generate C3a and C5a without activation of the entire complement cascade. 7 Indeed, C3a and C5a have been found in the airways under steady state conditions and in allergic inflammation. 6, 8 Interestingly, C5a exerts a dual role in allergic asthma. Pharmacological targeting of the C5aR during allergen sensitization with house-dust mite (HDM) extract or ovalbumin (OVA) 6, 9 or genetic deletion of C5 [9] [10] [11] or the C5aR 6,9 results in an increased allergic phenotype with high Th2 and Th17 cytokine production, suggesting a protective role for C5a during allergen priming. By contrast, blocking the C5aR during the allergic effector phase attenuates the allergic phenotype. 6, 12, 13 The increased maladaptive Th2 response following C5aR targeting is associated with an increased ratio of cDCs vs. pDCs and a decreased expression of B7-H1 and B7-DC on pDCs, 14 suggesting that C5a may directly regulate DC activity in the lung through C5aR activation. In support of this view, C5aR
À / À spleen-derived cDCs that were stimulated with OVA in the presence of the TLR2 ligand Pam3Cys 15 or C5aR À / À bone marrow (BM)-derived DCs that were stimulated with HDM extract 9 produce more IL-23 than wt DCs. To directly assess the impact of C5aR signaling in cDCs for the development of maladaptive Th2 and Th17 immunity, we have injected OVA-pulsed granulocyte macrophages colony-stimulating factor (GM-CSF)-differentiated BMDCs from C5aR-deficient mice intratracheally (IT) into wt BALB/c mice. Surprisingly, C5aR
À / À cDCs failed to promote a typical Th2 response, which was associated with a decreased potency of antigen processing and CD11b expression in vitro. Further, C5aR
À / À cDC-activated CD4 þ T cells suffered from accelerated cell death associated with decreased expression of the prosurvival protein Bcl-2 and upregulation of the proapoptotic proteins BimL and BimEL. In line with this finding, we found a decreased frequency of pulmonary OVA-specific CD4 þ T cells 9 days after adoptive transfer of C5aR À / À BM DCs. Finally, we observed a higher frequency of CD11c þ CD11b þ Gr1 þ F4/80 þ cells in BM cultures of C5aR À / À mice resembling myeloid-derived suppressor cells (MDSC). Importantly, MDSC from C5aR À / À mice expressed higher levels of nitric oxide synthase 2 (NOS2) than MDSC from wt mice in vitro. Further, the functional properties of MDSC from wt and C5aR À / À mice were qualitatively and quantitatively different with regard to their ability to block Th2, Th17, and Th1 maladaptive immune responses in vivo.
RESULTS

Impaired allergen uptake of BMDCs from C5aR-deficient mice
DCs are sentinels of the innate immune system that sample antigens, process, and present them through major histocompatibility complex (MHC) class II molecules to T cells. We first compared the potencies of BMDCs from wt and C5aR À / À mice to take up the model antigen OVA. For this purpose, we incubated BMDCs with fluorescein isothiocyanate (FITC)-conjugated OVA (FITC-OVA) and determined the fluorescence intensity within CD11b þ CD11c þ cells at different time points by flow cytometry ( Figure 1a) . As shown in Figure 1b , we found an increased fluorescence signal in wt DCs as early as 30 min after FITC-OVA administration, which reached a plateau after 180 min incubation. DCs from C5aR À / À animals showed a similar kinetic. However, the fluorescence signal was always lower in C5aR À / À DC. At the end of the observation period (240 min), the fluorescence signal in C5aR À / À DCs was decreased by 70% as compared with that in wt DCs (from 931±28 to 289±131). By contrast, antigen uptake of C3aR or C5L2-deficient DCs was similar to wt DCs (see Supplementary  Figure S1 online).
The signal of FITC-OVA is pH sensitive and can be quenched by acidic pH. To avoid this problem and to assess the impact of C5aR deficiency on antigen processing, we used DQ-OVA. Upon proteolytic degradation, photostable and pH insensitive green fluorescent peptides are released from DQ-OVA, reflecting antigen processing. Interestingly, we observed a substantial difference of the initial antigen processing between wt and C5aR À / À DCs. Already 15 min after allergen incubation, C5aR
À / À DCs showed an increase in the fluorescence signal, which was absent in wt DCs (Figure 1b) . Allergen processing in wt DCs became visible after 30 min but was still lower than in C5aR À / À DCs. However, during the next hour (60-120 min after allergen administration), the DMFI (mean fluorescent intensity) signal in wt DCs increased from 502 to 1,818, whereas it increased only to 946 in C5aR À / À DCs. At the end of the observation period (240 min), it reached 2,391±99 in wt DCs but only 1,322 ± 324 in C5aR À / À DCs. Thus, C5aR
À / À DCs start processing OVA quicker than wt DCs early after allergen uptake. However, 60 min after allergen incubation, most of the wt DCs homogenously process the OVA with a high pace, resulting in a dominant population of DQ-OVA hi cells and only a minor fraction of DQ-OVA lo cells (Figure 1c) . By contrast, two populations of C5aR À / À DCs can be differentiated, one that processes DQ-OVA with a similar pace as wt DCs and a second population that processes DQ-OVA at a much lower pace.
The process of OVA uptake and processing is complex and involves pinocytosis and receptor-mediated endocytosis. 16 Blocking of scavenger receptor-mediated endocytosis by poly-inosinic acid resulted in 85% or 75% reduction of the À / À mice and differentiated for 10 days in the presence of 20 ng ml À 1 granulocyte macrophages colony-stimulating factor (GM-CSF). On day 10, 3 Â 10 5 DCs were incubated for different periods with either fluorescein isothiocyanate (FITC)-or DQ-OVA (ovalbumin) to assess antigen uptake or processing. Cells were washed, stained with anti-CD11c-APC and anti-CD11b-APC-Cy7 and analyzed by flow cytometry. Cells incubated at 4 1C served as controls. As a measure of uptake/processing the DMFI (mean fluorescent intensity) was calculated. (b) Determination of antigen uptake using FITC-OVA (left panel) and antigen uptake and processing using DQ-OVA (right panel À / À BMDCs were pulsed overnight with DQ-OVA and transferred IT to wt BALB/c-recipient mice (Figure 2a) . Ten days later, mice were challenged IT with 1.5% OVA. Animals transferred with DQ-OVA-pulsed wt DCs showed a clear asthmatic phenotype, characterized by marked airway hyperresponsiveness (AHR; Figure 2b ) associated with strong eosinophilic and neutrophilic airway inflammation ( Figure 2c ). Histological examination of the airways confirmed the massive recruitment of inflammatory cells ( Figure 2d ) and provided evidence for strong mucus production within the bronchi (Figure 2e ). In addition to airway reactivity and inflammation, we also determined the development of maladaptive T-cell responses. As shown in Figure 2f , we found a dominant Th2 cytokine profile signature when lung cells were restimulated with OVA, associated with IL-17A and interferon-g (IFN-g) production. By contrast, transfer of DQ-OVA-pulsed DCs from C5aR À / À mice failed to drive a strong asthmatic phenotype as evidenced by a significantly lower airway resistance, a markedly decreased airway eosinophilia, and a strong decrease in mucus production (Figure 2b-e) . We also observed a trend toward decreased neutrophil numbers. The most striking finding was that the adoptive transfer of DQ-OVA-pulsed C5aR À / À DCs resulted in marginal Th2 cytokine production, which was at the level of unpulsed wt or C5aR À / À DCs ( Figure 2f) . Further, the IL-17A production decreased by 40% (from 1,698 ± 269 to 1,018 ± 149 pg ml
; unpulsed 393 ± 106 pg ml À 1 ). The tumor-necrosis factor-a (TNF-a) and the IFN-g production were not affected by the absence of C5aR. Taken together, these data suggest a critical role for C5aR signaling in BMDC-mediated induction of experimental allergic asthma.
As shown in Figure 1c (Figure 3a) . In line with a previous report, 4 we found that DCs with a low antigen uptake (DQ-OVA lo cells) were more potent asthma inducers than DCs with a high antigen uptake (DQ-OVA hi cells). AHR, airway inflammation, mucus production, and Th2 cytokine production were significantly higher in response to transfer of wt DQ-OVA lo cells as compared with wt DQ-OVA hi cells (Figure 3a-e) . We also found a trend toward higher IL-17A production ( Figure 3f ) in the wt DQ-OVA lo group, although this difference did not reach the level of statistical relevance. TNF-a and IFN-g levels were similar in both the groups. Similar to what we had observed with unsorted DC populations (Figure 2 ), C5aR deficiency resulted in decreased AHR, airway inflammation, mucus production, Th2, and Th17 cytokine production, whereas the IFN-g levels were comparable in the wt and C5aR
À / À DQ-OVA lo groups. Together, the decreased potency of C5aR À / À DCs to drive an allergic phenotype cannot be assigned to the higher frequency of DQ-OVA lo cells, as such cells were more potent to drive experimental allergic asthma than their DQ-OVA hi counterparts.
C5aR
À / À DCs express less CD11b and produce less Th17-cell-promoting cytokines in vitro
In search for mechanisms that may account for the decreased potency of C5aR À / À DCs to promote allergic asthma, we determined the frequency and the expression levels of CD11b, MHC class II, CD40, CD80, and CD86 on CD11c þ wt and C5aR À / À DCs before and 24 h after OVA incubation in vitro. As expected, 90% of wt and C5aR
À / À DCs co-expressed the CD11c and the CD11b markers before and after the OVA pulse. CD11c þ CD11b þ DCs were negative for the macrophage/DC progenitor markers CD115, CD117, CD135, and CX3CR1 (data not shown). Between 25-50% of the unpulsed CD11c 
CD11b
þ wt and C5aR À / À DCs expressed the co-stimulatory molecules CD80, CD86, and CD40, which increased significantly after OVA incubation (Figure 4a,b) . Interestingly, the frequency of MHC-II þ cells was significantly higher (75%) in C5aR À / À DCs than in wt DCs (20%). OVA stimulation increased the frequency of MCH-II þ cells in both the DC populations to almost 100%. Although almost all the DCs from wt and C5aR À / À mice were CD11b þ , we found a significantly lower expression of CD11b on resting and OVA-pulsed DCs from C5aR À / À origin. Further, the higher frequency of MHC-II þ DCs in resting BM cultures from C5aR À / À mice was associated with higher MHC-II expression. Although the frequency of MHC-II þ DCs was similar in BM cultures from OVA-activated wt and C5aR, the expression levels were still somewhat higher in C5aR À / À DCs. The increased frequency of CD80 þ , CD86 þ , or CD40 þ DCs in wt and C5aR À / À mice after OVA incubation was associated with and increased expression level of the costimulatory molecules ( Figure 4c) .
Next, we determined the production of cytokines that are critical for the differentiation of Th1, Th17, and regulatory T cells, such as IL-12p40, IL-12p70, IL-1b, IL-6, IL-23, IL-33, and TGF-b (Figure 4d) . Except for TGF-b, unpulsed wt or C5aR À / À DCs did not produce any of such cytokines. The TGF-b production was lower in C5aR À / À DCs as compared with wt DCs. By contrast, OVA stimulation resulted in significant production of all of the cytokines except of TGF-b, the levels of which were unchanged. Importantly, C5aR
À / À DCs produced significantly less Th17-inducing cytokines IL-1b, IL-6, and IL-23 ( Figure 4d ). Last but not the least, we found a minor increase in IL-12p70 production in the À / À mice and grown for 10 days in RPMI in the presence of granulocyte macrophages colony-stimulating factor (GM-CSF). On day 9, DCs were pulsed overnight with 1 mM DQ-OVA or with phosphate-buffered saline. The next day, 1 Â 10 6 unpulsed or pulsed DCs were administered intratracheally (IT) into BALB/c wt recipients. After 10 days, recipient mice were challenged IT with 1.5% ovalbumin (OVA). Seventy-two hours after the injection, airway responsiveness was determined. Subsequently bronchoalveolar lavage (BAL) fluid, lung cells, and tissues were collected for further analysis. BALB/c mice receiving unpulsed DCs served as controls. 
C5aR
À / À DCs as compared with wt DCs. Expression of IL-33 was slightly above the detection limit of the assay and not affected by the lack of C5aR.
À / À DCs have an impaired ability to drive Th1-and Th17-cell differentiation and accelerate activated CD4 þ
T-cell death
In the next step, we did setup co-cultures of OVA-stimulated DCs with OVA T-cell receptor (TCR)-transgenic DO11.10 CD4 þ T cells from RAG2-deficient mice. First, we assessed the ability of wt and C5aR
À / À DCs to regulate T-cell proliferation. For this purpose, DCs were stimulated with OVA in the presence of carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled CD4 þ T cells for 4 days. As expected, T cells co-cultured with wt cells strongly proliferated as evidenced by the decrease of the CFSE signal over time. C5aR
À / À DCs were equally potent in driving CD4
þ T-cell proliferation ( Figure 5a ). Next, we assessed the ability of wt and C5aR
DCs to drive allergen-specific differentiation of naive CD4 þ T cells. After 4 days of co-culture, wt DCs promoted the production of the Th2 cytokines IL-4, IL-10, and IL-13, the Th17 cytokine IL-17A, and the Th1 cytokine IFN-g ( Figure 5b ). We found similar levels of Th2 cytokines in C5aR
À / À DC cocultures. By contrast, IL-17A production was significantly reduced in C5aR
À / À DC co-cultures. As described before, IFN-g production was also reduced. 15, 20, 21 These data are in line with the decreased IL-17A production associated with the decreased neutrophilic airway inflammation that we had observed after adoptive transfer of C5aR À / À DCs into BALB/c mice (Figures 2f and 3f) . By contrast, C5aR
DCs are perfectly suited to drive Th2 effector cell differentiation in vitro, suggesting that the failure of C5aR À / À DCs to promote Th2 cytokine production in vivo does not result from a defect to initiate Th2-cell differentiation.
Following the clonal expansion and effector T-cell differentiation in response to DC-mediated activation, most of the T cells are deleted by apoptosis and only a few cells become memory T cells. 22 To assess apoptotic deletion of effector T cells, we first determined the frequency of DAPI
þ T cells on days 4 and 7. As expected, on day 4, only a minor fraction of CD4 T cells was apoptotic (data not shown). On day 7, 30% of the T cells from the C5aR
À / À DC co-culture but only 8% from the wt DC coculture were DAPI þ ( Figure 5c ).
The decreased survival of T cells in the C5aR
À / À DC co-culture on day 7 was associated with a significant decrease in IL-2 ( Figure 5d ) and a six or threefold increase in the two isoforms of the pro-apoptotic molecules B-cell lymphoma 2 (BCL-2)-interacting mediator of cell death (Bim) BimL and BimEL ( Figure 5e ). We found no impact on p53-upregulated modulator of apoptosis (Puma) expression, which can cooperate with Bim in activated T-cell apoptosis. 23 Moreover, we observed a threefold decrease in the pro-survival molecule Bcl-2 in C5aR
À / À DC co-cultures. By contrast, we found no production of BCL-X L (data not shown). These data indicate that the signals provided by C5aR À / À DCs to OVA-specific T cells are sufficient to promote their initial clonal expansion and differentiation into Th2 effector cells. However, in contrast to the wt DCs, C5aR
À / À DCs drive OVAspecific T cells into the contraction phase at an earlier time point.
C5aR
À / À DCs have an impaired ability to induce stable T-cell responses in vivo
Next we aimed at assessing the potency of C5aR À / À DCs to promote the expansion and the survival of allergen-specific CD4 þ T cells in vivo. For this purpose, we injected CFSElabeled OVA TCR-transgenic CD4 þ T cells from DO11.10 RAG2 À / À mice intravenously into wt recipient mice. The next day, we transferred DQ-OVA-pulsed wt or C5aR À / À DC IT into wt mice. Five or nine days later, we assessed the proliferation and the frequency of OVA-specific T cells in the lung and in pulmonary lymph nodes (Figure 6a ). On days 5 and 9, the frequencies of DO11.10 TCR þ T cells in the lymph nodes did not differ between the two treatment groups (Figure 6b,c) . However, we noticed slightly decreased T-cell proliferation in the lymph nodes after adoptive transfer of C5aR À / À DCs (Figure 6b ). In the lung, the CFSE signal on days 5 and 9 were too low to assess any differences in T-cell proliferation (data not shown), suggesting that the OVAspecific T cells that we detected in the lung were highly proliferated effector T cells that had migrated from the pulmonary lymph nodes into the lung. On day 5, we already found a slightly decreased frequency of DO11.10 TCR þ T cells in the lung of wt mice adoptively transferred with C5aR À / À DCs. On day 9, the frequency of DO11.10 TCR þ T cells in the lung was reduced by 70% in wt mice that had received C5aR
À / À DCs as compared with mice adoptively transferred with wt DCs (Figure 6d,e) . These data are in line with our in vitro findings of increased T-cell apoptosis after stimulation with C5aR À / À DCs. Together, our findings 
suggest that C5aR
À / À DCs promote T-cell proliferation in the pulmonary lymph with a similar potency as wt DCs. However, once activated, OVA-specific effector T cells that have migrated back into the lung suffer from accelerated cell death, resulting in a decreased frequency of OVA-specific T cells after primary antigen encounter. Increased frequency of myeloid-derived suppressor cells in BMDC preparations from C5aR-deficient mice MDSC are a heterogeneous population of myeloid progenitor cells and immature myeloid cells that reside in the BM and with low frequency in the spleen. 24 They express the CD11b and Gr-1 markers and can be further divided into CD11b
. 25 They are potent suppressors of T-cell functions. Recent reports provide evidence that MDSCs can be induced in BM cultures by IL-6 26 or lipopolysaccharide 27, 28 treatment in vitro and in murine airways 28 and can suppress Th2 effector functions. Intense cross-talk between TLR and C5aR signaling has been shown previously. 15, 29, 30 Further, during GM-CSF differentiation, BM cells locally produce C5 and C5a. 21 Based on these findings and our data that C5aR À / À BMDCs differ in antigen uptake and processing, CD11b and MHC-II expression as well as in their cytokine profile, we hypothesized that C5aR deficiency during DC differentiation may also affect the differentiation of MDSCs. As shown in Figure 7a À / À mice, most of them had a monocytoid morphology (Figure 7b) . In addition to their surface marker expression, MDSCs can be functionally characterized by the production of free radicals, which depends on the expression of arginase 1 and NOS2 among other mechanisms. 24 We found that CD11b (Figure 8a ). After stimulation with phosphate-buffered saline or DQ-OVA, the cell mixture was administered IT into BALB/c wt mice, which were re-challenged with OVA 10 days later. Addition of C5aR À / À SC had no impact on airway resistance (Figure 8b ). By contrast, the eosinophilic and neutrophilic pulmonary infiltration observed with OVA-pulsed wt BMDCs was markedly reduced in the presence of C5aR À / À SCs (Figure 8c,d) . By contrast, goblet cell hyperplasia and mucus production were comparable in the two groups (Figure 8e) . IL-4, IL-5, and IL-10 levels were markedly reduced in the presence of C5aR À / À SCs (Figure 8f) . The reduced IL-5 levels fit well with the decreased eosinophilic airway inflammation, as IL-5 is critical for the mobilization of eosinophils from the BM. By contrast, addition of C5aR À / À SC had no impact on IL-13 production (Figure 8f) , which is in line with our data that the C5aR À / À SC treatment group showed no change in AHR (Figure 8b ) and mucus production ( Figure 8e) . Finally, we found no impact of C5aR À / À SC on TNF-a, IL-17, and IFN-g production ( Figure 8f) . The high IL-17 levels in the C5aR À / À SC treatment group are surprising, as we found a substantial decrease in neutrophil numbers in this group as compared with the untreated control group. Recent reports suggest that IL-17 and TNF-a are critical factors for airway neutrophilia. 31 (Figure 9a ). After stimulation with phosphate-buffered saline or DQ-OVA, the cell mixture was administered IT into BALB/c wt mice, which were re-challenged with OVA 10 days later. Addition of wt SCs strongly reduced airway resistance (Figure 9b) . Further, eosinophilic and neutrophilic airway inflammation observed with OVA-pulsed wt BMDCs was markedly reduced in the presence of wt SCs (Figure 9c,d) . However, total cells and lymphocyte numbers were not affected. Also, goblet cell hyperplasia and mucus production were similar between the two groups (Figure 9e) . IL-4, IL-5, and IL-13 levels were markedly reduced in the presence of wt SCs, whereas we found only a trend for the reduction of IL-10 ( Figure 9f) . The decreased IL-13 levels fit well with the decreased airway resistance. Finally, TNF-a levels increased, whereas IL-17A decreased, although this drop in IL-17A did not reach the level of statistical significance (Figure 9f) .
DISCUSSION
C5a exerts a dual role in allergic asthma. During the effector phase, it drives the allergic inflammation, 6, 12, 13 whereas it protects from the development of maladaptive Th2 immune responses during allergen priming. 6, 14 Given that DCs are of major importance for allergen sensitization, we hypothesized that C5a may suppress DC activation at allergen encounter. We found a mixed eosinophilic and neutrophilic airway inflammation that was associated with AHR and Th2, Th17, and Th1 cytokine production. Surprisingly, the allergic phenotype was markedly reduced after adoptive transfer of C5aR-deficient cDCs. C5aR
À / À DCs failed to promote significant allergen-specific Th2 cytokine production, resulting in decreased AHR and minor allergenspecific mucus production. This is in sharp contrast to our previous findings and suggests that in vivo C5aR-activation on other cell types besides DCs such as tissue resident alveolar macrophages or airway epithelial cells has to be considered, both of which express C5aR 34, 35 and exert immunoregulatory properties. Indeed, airway epithelial cells secrete several cytokines, including GM-CSF, TSLP, IL-25, IL-33, and IL-1 family members, upon allergen contact that promote DC maturation enabling them to differentiate naive T cells into Th2 effector cells. 1 In addition to C5aR, C5a can also interact with a second receptor, C5L2, which controls the development of Th1 and Th17 cells in experimental allergic asthma at the DC/T cell interface and promotes Th2 immune responses independent of pulmonary DCs. 36 This effect may become dominant in vivo in the absence of C5aR. Finally, C5aR signaling in BMDCs may inappropriately reflect C5aR-mediated regulation of the distinct pulmonary DC subsets in vivo. In fact, C5aR targeting regulates the frequency of pulmonary pDCs expressing the costimulatory molecules B7-H1 and B7-DC, which is critical for Th2 cytokine production from CD4 þ T cells.
14 After adoptive transfer of C5aR À / À BMDCs, the airway inflammation was not only lower but was dominated by neutrophils. Eosinophilic airway inflammation is mainly driven by IL-5, whereas TNF-a and IL-17A synergize to recruit neutrophils into the airways. 32 In line with this view, C5aR
DCs promoted allergen-specific production of TNF-a and IL-17A, although the IL-17A levels were lower as compared with the levels produced by wt DCs. Our in vitro data suggest that the decreased Th17-cell development results from a deficit of C5aR À / À DCs to produce IL-1b, IL-6, and IL-23. Such cytokines either promote Th17-cell differentiation or serve as growth factors for Th17 cells. 37 In support of this view, we found decreased IL-17A production in co-cultures of C5aR À / À DCs with OVA transgenic CD4 þ T cells when compared with wt DC cultures. Together, our findings support a model in which the C5a-C5aR axis is required for BMDCdriven Th17-cell differentiation. In contrast to our findings, Lajoie et al. 9 recently reported that C5aR-deficient BMDCs produce more IL-23 than wt DCs, which was associated with strong Th17 immune responses in a HDM-model of pulmonary allergy. Further, C5aR deficiency did not affect DC-driven IL-6 and IL-1b production in their study. The fact that HDM extract has been used to activate BMDCs may explain the opposing results. In line with the HDM study, spleen-derived C5aR À / À DCs, which were stimulated with a TLR2 ligand, produce more IL-23 and promote Th17-cell differentiation. 15 However, similar to our data, Strainic et al. 20 found reduced IL-23p19 mRNA levels in OVA 323-330 peptide-stimulated BMDC/OT-II T-cell co-cultures, when the C5aR and the C3aR were pharmacologically targeted. Together, these findings suggest a complex regulatory role for the C5a-C5aR axis in Th17 differentiation that depends on the nature of the antigen (HDM vs. OVA) and the subset of DCs that is activated (BMDCs vs. spleen DCs). The importance of the antigenpresenting cell type is further stressed by data obtained with mouse peritoneal macrophages and human monocytes. In this setting, C5a drives Th17-cell differentiation by a strictly IL-6-dependent mechanism. 30, 38, 39 In future studies, it will be important to delineate the signaling pathways activated by the complex allergens like HDM and the cross talk between C5aR, C5L2, and TLRs in the context of C5aR and C5L2 deficiencies. As we and others have shown before, cross-regulation exists between the different anaphylatoxin receptors 14, 40 that can affect the signaling program in different DC subsets ultimately defining the production of cytokines that regulate the lineage commitment of naive Th cells.
The unexpected finding that the absence of the C5aR in BMderived cDC results in decreased Th2 immune responses in vivo was associated with: (i) a functional defect of C5aR À / À DCs to appropriately take up and process the model antigen OVA; and (ii) a higher frequency of more mature DCs expressing higher levels of MHC-II. It has been demonstrated that antigen uptake and processing correlates with the maturation status of DCs. 41, 42 Our data suggest that C5aR activation during GM-CSF-mediated DC differentiation is an important signal that keeps DCs in a more immature state required for antigen sensing. We were not able to assign the decreased potency of antigen uptake to a particular endocytosis pathway. Scavenger receptor-mediated endocytosis and micropinocytosis were 
both reduced in C5aR
À / À BMDCs. In line with previous studies 4, 43 we found that cells with a lower antigen uptake were more potent inducers of Th2 cytokines. However, we did not observe a shift towards a more pronounced production of IFN-g or IL-17 as reported for CD11b þ CD103 þ lung DCs in the presence of high antigen concentration. 4 Despite the decreased uptake of OVA, C5aR
À / À DCs were not impaired in their ability to promote allergen-specific expansion of CD4 production from CD4 þ T cells in vitro was not affected. However, we observed an accelerated apoptosis rate of C5aR
þ T cells in vitro by activation of the intrinsic death pathway. Concomitant with a rapid decrease in IL-2, we found a substantial upregulation of the pro-apoptotic molecule Bim and a decrease of the pro-survival mediator Bcl-2. At this point, we do not know whether the faster contraction of activated CD4 þ T cells results in lower frequency of memory T cells. However, it is tempting to speculate that the failure of C5aR À / À cDCs to mount a strong Th2 immune response in vivo is due to a reduced number of Th2 memory cells. In support of this view, we observed a markedly reduced frequency of antigen-specific CD4 þ T effector cells that had homed to the lung 9 days after antigen-specific stimulation with OVA-pulsed BMDC from C5aR À / À mice. At this point, we cannot rule out that the decreased frequency of OVA-specific T cells in the lung results from decreased migration from the lymph nodes to the lung. However, as the frequency of OVAspecific T cells is only slightly reduced at day 5, we consider it more likely that the reduced frequency of OVA-specific T cells on day 9 is due to an increased apoptosis rate of already migrated cells. An impact of C5aR signaling on T-cell viability has been demonstrated before, however, it has been mainly attributed to a lack of C5aR signaling in T cells. Strainic et al. 20 described an autocrine feedback loop in CD4 þ T cells, in which T cells constitutively produce C3a and C5a that bind to their cognate anaphylatoxin receptors, thereby activating an AKTdependent signaling pathway preventing programmed cell death. Indeed, these authors found a decreased half-life of naive, unstimulated T cells. Further, the same authors found decreased levels of Bcl-2 but increased levels of caspase 3 and Fas in CD3/CD28-activated mouse C5aR
À / À T cells. 44 An anti-apoptotic role for C5a has also been shown for human T cells. 39 Together, the available data suggest a complex, antiapoptotic role for C5a on T cells. Importantly, C5aR deficiency on T cells seems to affect steady state survival 20 and early T-cell apoptosis during T-cell expansion, 44 whereas C5aR deficiency in antigen-presenting cells, at least in BMDCs, promotes accelerated T-cell apoptosis during the contraction phase.
Another important finding of this study is the impact of C5aR signaling on the development of a myeloid-derived suppressor population from BM cells. In BM cell cultures of C5aR-deficient mice, we found a 2.5-fold increase in a CD11b hi
CD11c
int Gr-1 þ F4/80 þ SC population as compared with BM cells from wt mice. This expansion of SCs in the absence of C5aR appears to be independent of the SCpromoting cytokine IL-33, as we found very low levels of IL-33 in the BMDC cultures, which were not affected by the lack of C5aR. These cells phenotypically resembled M-MDSCs. 25 MDSCs can be induced in vitro 27 and in vivo in the lung by activation of the TLR4/MyD88 pathway and suppress allergen-induced airway inflammation. 28 Further, distinct MDSC populations accumulate in the lung during experimental allergic asthma that either enhance or suppress T-cell responses. 45 Wt and C5aR SCs both expressed arginase-1 and NOS2, the latter of which was significantly higher in C5aR SCs. The importance of NO for the T-cell suppressor activity of BMderived MDCS has been shown before. 45, 46 Interestingly, we found that in a Th2 environment, i.e., high IL-4, NOS2 expression is downregulated, whereas arginase 1 is upregulated.
These data may indicate that the local cytokine milieu defines the pathway by which SCs exert their immunoregulatory functions. Indeed, in a tumor model, C5a recruited highly suppressive G-MDSCs and increased the production of reactive oxygen and nitrogen species in M-MDSCs. 47 In the OVA asthma model, we found a substantial decrease in the production of most Th2 cytokines and a marked reduction of the mixed eosinophilic/neutrophilic airway inflammation following adoptive transfer of a small number (3 Â 10 4 ) of both wt and C5aR À / À SCs. An important quantitative difference between wt and C5aR À / À SCs is that the suppression of the airway inflammation is stronger after administration of C5aR À / À SCs as evidenced by the significant reduction of total cell and lymphocyte numbers and a stronger reduction of airway eosinophil and neutrophil numbers. These findings suggest that the decreased Th2 cytokine production and the low airway inflammation that we have observed in response to the adoptive transfer of BMDCs from C5aR À / À mice results from a suppressive effect of a small number of C5aR À / À SCs that is present in the BM cell preparation. Wild-type (WT) and C5aR
À / À SCs both reduced the production of IL-4, IL-5, and IL-10, although the magnitude of the reduction was higher when we used SCs cells from C5aR À / À mice. Importantly, wt but not C5aR À / À SCs suppressed IL-13. In line with the failure of C5aR
À / À SCs to block IL-13, we observed no reduction in AHR and mucus production, both of which have been attributed to IL-13. 48 Interestingly, the reduction of IL-13 levels by wt SCs resulted in reduced AHR but did not affect the mucus production. Given that IL-13 is an important trigger of AHR and mucus production, the differences maybe explained by two effects: (i) although the IL-13 levels are significantly lower in the presence of wt SCs, they still reach a concentration of 15 ng ml À 1 , which seems to be sufficient to drive substantial mucus production; and (ii) AHR is not only regulated by IL-13 but also by IL-17A. In contrast to C5aR À / À SCs, administration of wt SCs reduced the IL-17A production from 1.4 to 0.5 ng ml À 1 suggesting that the combination of decreased IL-13 and IL-17A concentrations caused the decreased AHR in response to wt SCs. The finding that C5aR À / À SCs did not block the IL-17A production is in line with our observation that C5aR-deficient BMDCs produce less Th17-inducing cytokines. Despite the high IL-17A levels, we observed a marked decrease in neutrophil numbers. Our data suggest that in an environment with low IL-5 and only a minor number of eosinophils, even high IL-17A and TNF-a concentrations 32 do not drive the accumulation of neutrophils in the airways. This effect might be attributed to the low number of eosinophils as C3a-and C5a-activated eosinophils drive polarization and recruitment of neutrophils. 49 Another qualitative difference between wt and C5aR À / À SCs is that wt but not C5aR À / À SCs significantly reduced the production of IFN-g. Taken together, our findings suggest that the expression of the C5aR on BM cells regulates the expansion of a CD11b hi CD11c int Gr-1 þ F4/80 þ SC population. SCs from C5aR
À / À and wt mice exert different abilities to regulate the differentiation of CD4
þ Th cells into Th2, Th17, and Th1 cells. Wt SCs exert a broad spectrum of inhibition and can block the differentiation towards Th2, Th17, and Th1 cells. By contrast, C5aR
À / À SCs have lost their ability to block Th1 and Th17 lineage commitment. They are still able to block the production of most Th2 cytokines, including IL-4, IL-5, and IL-10, but they lack the ability to block IL-13 production. In future studies, it will be important to delineate whether C5aR also controls the expansion and the functional properties of MDSC in the lung in mouse models of experimental allergic asthma that use allergens relevant to human allergy such as HDM, ragweed, or birch pollen.
METHODS
Mice. BALB/c mice (Charles River, Sulzfeld, Germany), C3aR
À / À , C5L2 À / À , and C5aR À / À mice on BALB/c background were bred and maintained in the University of Lübeck specific pathogen-free facility and used at 8-12 weeks of age. Animal care was provided in accordance with German rights. These studies were reviewed and approved by the Schleswig-Holstein state authorities (Nr. V312.72241.122-39).
BMDC preparation and induction of the allergic phenotype in vivo.
BM cells were isolated from naive BALB/c, C3aR
À / À , C5L2 À / À , and C5aR À / À mice by flushing femurs and tibias with RPMI medium. Red blood cells were lysed using 155 mM NH 4 Cl, 10 mM NaHCO 3 , 0.1 mM EDTA (all Sigma-Aldrich, Hamburg, Germany). BM cells (10 6 cells ml À 1 ) were cultured in complete RPMI 1640 culture medium (PAA, Cölbe, Germany) supplemented with 10% fetal bovine serum (PAA), 2 mM L-glutamine, 100 units ml À 1 penicillin, 100 mg ml À 1 streptomycin (all from GIBCO Invitrogen, Darmstadt, Germany) and 20 ng ml À 1 recombinant murine GM-CSF (PeproTech, Hamburg, Germany). Cultures were incubated at 37 1C, 5% CO 2 for 10 days. On day 9, cells were pulsed overnight with 1 mM DQ-OVA (Invitrogen) in vitro. To induce pulmonary allergy in vivo, DQ-OVApulsed DCs were harvested on day 10 and 10 6 DCs were injected IT into the airways of naive BALB/c mice. Recipient mice were challenged IT once after 10 days with 50 ml 1.5% OVA (grade V, Sigma-Aldrich). Unpulsed DCs were injected into BALB/c recipients following the same protocol as controls. After 72 h, airway responsiveness was determined and lung tissue samples were harvested for further analysis.
In vivo correlation of antigen uptake/processing and asthma induction. Day-9 wt or C5aR À / À BMDCs (1 Â 10 6 per well) were stimulated with 1 mM DQ-OVA in complete RPMI 1640 culture medium (PAA) and 20 ng ml À 1 recombinant murine GM-CSF (PeproTech) for 24 h. After staining with anti-CD11c-APC (allophycocyanin) and anti-CD11b-APC-Cy7, CD11c
þ CD11b þ DQ-OVA hi cells were separated from the rest of the cells by fluorescence-activated cell sorting using a MoFlo cell sorter (Beckman Coulter, Krefeld, Germany). The sorted DQ-OVQ hi and DQ-OVA lo cells were separately transferred into naive BALB/c. On day 10, mice were challenged with 1.5% OVA as above. After 72 h, airway responsiveness was determined, and lung tissue samples were harvested for further analysis.
In vivo assessment of wt and C5aR
À / À suppressor cell function.
Day-9 wt and C5aR À / À BMDCs were stained with anti-CD11c-APC, anti-CD11b-APC-Cy7, anti-F4/80-PE (phycoerythrin) and anti-Gr-1-FITC (all eBioscience, Frankfurt, Germany). Cells positive for all the four markers were considered as SCs and sorted using a MoFlo cell sorter. In all, 30,000 SCs were added to 10 6 wt BALB/c DCs and incubated overnight with 1 mM DQ-OVA. On day 10, cells were harvested and adoptively transferred into naive BALB/c. All subsequent immunizations and analyses were performed as described above.
Allergen-induced AHR. AHR was measured in anesthetized mice that were mechanically ventilated using a FlexiVent (SciReq, Montreal, Quebec, Canada). Aerosolized acetyl-b-methyl-choline (metacholine) (0, 1, 2.5, 5, 10, 25, and 50 mg ml À 1 ; Sigma-Aldrich) was generated by an ultrasonic nebulizer and delivered in-line through the inhalation port for 10 s. Airway resistance was measured 2 min later.
Collection of blood and bronchoalveolar lavage fluid. Bronchoalveolar lavage samples were obtained as described. 6 Differential cell counts of bronchoalveolar lavage cells were obtained after spinning the cells down onto slides and staining with May-Grünwald-Giemsa stain (Sigma-Aldrich). A minimum of 200 cells were morphologically differentiated by light microscopy.
Isolation of pulmonary cells and cytokine measurements. Collagenase/DNase I (both Sigma-Aldrich) digests of the lungs were prepared to obtain single lung cell suspensions. 6 Single-cell suspensions (2.5 Â 10 5 ) were restimulated ex vivo with 1 mM OVA or with medium alone, and incubated at 37 1C for 72 h in complete RPMI 1640 culture medium. Production of interleukin (IL)-4, IL-5, IL-10, IL-13, IL-17A, IFN-g, and TNF-a in culture supernatants was determined using DuoSet ELISA kits (R&D Systems, Wiesbaden, Germany) following the manufacturer's protocol. The sensitivities were 16 pg ml À 1 for IL-4 and IL-17A, 31 pg ml À 1 for IL-5, IL-10, IFN-g, and TNF-a, and 62.5 pg ml À 1 for IL-13.
Lung histology. Lung histological staining, detection, and quantification of mucus cell content were done as described. 48 Briefly, lungs were excised and fixed in 3.7% formalin. Fixed tissues were then washed with 70% ethanol, dehydrated, embedded in paraffin, and cut into 5 mm sections. Slides were stained with hematoxylin and eosin and periodic acid-Schiff (PAS). For quantification of mucus production in the airway epithelium, PAS positive and PAS negative airways were counted by light microscopy from four lung sections per animal.
In vitro analysis of antigen uptake and processing. Day-10 wt, C3aR À / À , C5L2 À / À or C5aR À / À BMDCs (10 6 /well) were stimulated with DQ-or FITC-OVA, 10 mg ml À 1 , in complete RPMI 1640 culture medium (PAA) for 0, 15, 30, 60, 90, 120, 180, or 240 min at 37 or 4 1C as a control. Uptake and processing were detected in the FITCchannel after staining with anti-CD11c-APC and anti-CD11b-APCCy7 on a BD-LSRII (Becton Dickinson, Heidelberg, Germany). To analyze pinocytosis or scavenger receptor-mediated endocytosis, cells were incubated with dimethylamiloride (500 mM, Sigma-Aldrich) or poly-inosinic acid (144 mM, Sigma-Aldrich) 30 min before incubation with FITC-/DQ-OVA as described previously. 16 In vitro stimulation of BMDCs. Wt or C5aR
À / À BMDCs (1 Â 10 6 per well; day 9) were stimulated with DQ or FITC-OVA, 1 mM, in complete RPMI 1640 culture medium) and 20 ng ml À 1 recombinant murine GM-CSF (PeproTech) at 37 1C for 24 h. Secretion of IL-1b, IL-6, IL-12p40, IL12p70, IL-23, and TGF-b in culture supernatants was determined using DuoSet ELISA kits (R&D Systems) following the manufacturer's protocol. The sensitivities were 16 pg ml À 1 for IL-1b, IL-6, IL-12p40, and IL-33, 31 pg ml À 1 for TGF-b, and 39 pg ml À 1 for IL-23 and IL-12p70. Expression of surface markers was analyzed using anti-CD11c-APC, anti-CD11b-APC-Cy7, anti-MHC-II-PE, anti-CD80-biotin conjugated to Qdot 585, anti-CD86-biotin conjugated to Qdot 655 and anti-CD40-biotin conjugated to Qdot 585 (all antibodies from eBiosciences, Qdots from Invitrogen) on a BD LSRII (Becton Dickinson). Day-9 BM cells were stained with anti-CD11c-APC, anti-CD11b-APC-Cy7, anti-Gr-1-FITC, and anti-F4/80-PE (all from eBioscience). Cells positive for all four markers were considered as SCs and sorted using a MoFlo cell sorter. SCs were cultured in complete RPMI 1640 for 24 h at 37 1C and 5% CO 2 . Expression levels for arginase 1 and NOS2 were evaluated by RT-PCR in resting cells or after stimulation with 50 ng ml À 1 IL-4 (R&D Systems).
RNA isolation and real-time PCR. RNA was isolated using Trizol reagent according to the manusfacturer's instructions (Invitrogen). Reverse transcription reaction was performed after DNAse I treatment of the RNA (Fermentas, Thermo Fisher Scientific Inc., Waltham, MA) using first strand cDNA synthesis kit (Revertaid Premium, Fermentas). Quantitative PCR was done using iQ Sybr green (Bio-rad, München, Germany) on a IQ iCycler PCR machine (Bio-rad) using the following primers (Eurofins, Reichenwalde, Germany): actin À / À mice were isolated from spleen by magnetic selection using the CD4 isolation kit II (Miltenyi, Bergisch-Gladbach, Germany) according to the manufacturer's instructions, labeled with CFSE (1 mM; Molecular Probes, Darmstadt, Germany), and 1 Â 10 5 cells were co-cultured with BMDCs from wt or C5aR À / À mice. Four days later, cells were harvested, stained with anti-CD4-APC (eBioscience), and assessed for cell proliferation by flow cytometry on a BD LSRII (Becton Dickinson) and for cytokine production by ELISA. Analyzed cytokines were IL-4, IL-5, IL-10, IL-13, IL-17, and IFN-g (detection limits are indicated above, all DuoSets from R&D Systems). Further, on day 7, IL-2 levels were assessed by ELISA (detection limit 16 pg ml À 1 , DuoSet R&D Systems), cell survival was evaluated by staining cells with anti-CD4-APC and 3 mM DAPI (Sigma), and RNA was isolated to analyze pro/ anti-apoptotic molecules by real-time PCR as described previously. 50 
In vivo expansion of OVA-TCR transgenic T cells by wt and C5aR
À / À DCs. OVA-specific CD4 þ T cells were purified from the spleens of DO11.10/Rag2 À / À mice by magnetic-activated cell sorting using the CD4 isolation kit II (Miltenyi) according to the manufacturer's instructions. Purified T cells were labeled with CFSE (1 mM; , Molecular Probes) and 5 Â 10 5 cells were intravenously injected into wt recipient mice. After 24 h, 1 Â 10 6 BMDCs, stimulated for 24 h with 1 mM DQ-OVA (Molecular Probes), were harvested, washed with phosphate-buffered saline, and IT transferred into wt recipient mice. Five or nine days later, mice were killed, and the lung and lymph nodes were excised. Collagenase/DNase I (both Sigma-Aldrich) digests of the lungs were prepared to obtain single lung cell suspensions. To determine the frequency of OVA-specific CD4 þ T cells in the lung and the lymph nodes, cells were stained with APC-labeled DO11.10 TCRspecific antibody KJ-126 (eBiosciences) and analyzed by flow cytometry.
Statistical analysis. Statistical analysis was performed using the GraphPad Prism version 4 (GraphPad Software, La Jolla, CA). Statistical differences were evaluated by either ANOVA, paired or unpaired t-test. P-values o0.05 were considered statistically significant.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
